Abstract 3455: Prevalence of monoclonal gammopathy of undetermined significance (MGUS) in a Western Nigerian population
Celine M. Vachon(Cornell University), Solomon O. Rotimi(Covenant University), Shaji Kumar(Mayo Clinic in Arizona), Opeyemi C. De Campos(Covenant University), Linda B. Baughn(Mayo Clinic in Arizona), David Murray(University of Alberta), Joselle Cook(Mayo Clinic), Susan L. Slager(Mayo Clinic in Arizona), Titilope Dokumu(Covenant University), Danelle Moonen(Mayo Clinic in Arizona), Elizabeth E. Brown(University of Alabama at Birmingham Hospital), Oluwakemi A. Rotimi(Covenant University), Cristine Allmer(Mayo Clinic in Arizona), Aaron D. Norman(Mayo Clinic in Arizona)
Cited by 1
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862